Article
ELAC2 is a functional prostate cancer risk allele.
Trends in molecular medicine - 1 Aug 2023
Blinka Steven, Mishra Rashmi, Hsieh Andrew C
Abstract excerpt
Stentenbach and colleagues have unveiled a functional role of a human germline mutation found in the ribonuclease (RNase) Z enzyme, ELAC2, in prostate cancer. Here, we discuss the importance of these findings in enhancing our understanding of how risk variants enable prostate cancer progression and the post-transcriptional mechanisms underlying oncogenesis.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
